all Harvard Stem Cell Institute stories

From stem cells to functioning strip of heart muscle

404132862 — Thu, 15 Oct 2009 14:00:00 -0400

A team of Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital (MGH) and collaborators at Harvard’s School of Engineering and Applied Sciences (SEAS) has taken a giant step toward the possibility of using human stem cells to repair damaged hearts.

Harvard team grows heart muscle from stem cells

404132862 — Thu, 15 Oct 2009 17:18:08 -0400

Need a new heart? Grow your own

404132862 — Sat, 10 Oct 2009 13:07:34 -0400

Researchers Take Another Stem Cell Step

404132862 — Thu, 08 Oct 2009 16:10:29 -0400

Three Harvard teams to receive $9 million each in federal funding for stem cell research

404132862 — Thu, 08 Oct 2009 10:11:45 -0400

Three teams of Harvard Stem Cell Institute (HSCI) researchers are slated to receive $27 million over seven years in National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders. The NHLBI Progenitor Cell Biology Consortium will consist of nine research hubs, each involving multidiscplinary teams from two academic medical centers.

Harvard team reports major step forward in cell reprogramming

404132862 — Thu, 08 Oct 2009 12:00:00 -0400

A team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in treating diseases in patients.

NIH funds risky, potentially transformative research by Harvard faculty members

404132862 — Thu, 24 Sep 2009 11:17:05 -0400

Eighteen faculty members at Harvard and Harvard-affiliated institutions are among 115 scientists nationally whose promising and innovative work was recognized today with the announcement of three grant programs by the National Institutes of Health (NIH).

New steps forward in cell reprogramming

404132862 — Sun, 09 Aug 2009 13:00:20 -0400

Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital (MGH) have substantially improved the odds of successfully reprogramming differentiated cells into induced pluripotent stem cells (iPS) by blocking the activity of the gene that instructs the cells to stop dividing.

First molecular steps to childhood leukemia identified

404132862 — Wed, 15 Jul 2009 13:52:21 -0400

A Harvard research based at Massachusetts General Hospital has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) – the most common cancer in children – initiates the disease process. In the July issue of Cell Stem Cell, they describe how expression of this mutation in hematopoie

Glimpsing the birth of our earliest reproductive cells

404132862 — Mon, 13 Jul 2009 11:20:24 -0400

It has long been a mystery how the developing embryo designates those rare, precious cells destined to produce sperm and eggs -- enabling us to have offspring - since these primordial germ cells' existence is fleeting and hard to spot with the tools of biology.

Harvard researchers react to new embryonic stem cell guidelines

404132862 — Mon, 06 Jul 2009 16:06:49 -0400

Scientists find master heart cell - Harvard discovery gives new tools for drug development

404132862 — Thu, 02 Jul 2009 14:06:21 -0400

Human cardiac master stem cells identified

404132862 — Wed, 01 Jul 2009 12:59:00 -0400

Harvard Stem Cell Institute researchers at Massachusetts General Hospital have identified the earliest master human heart stem cell from human embryonic stem cells - ISL1+ progenitors - that give rise to a family of cells that form the essential portions of the human heart.

Massachusetts Lt. Governor tours Harvard research facilities

404132862 — Fri, 26 Jun 2009 13:43:08 -0400

Massachusetts Lt. Governor Timothy Murray on Wednesday toured Harvard labs in both Cambridge and Boston.

"The Patrick Administration has been very supportive of the university research sector in Massachusetts and we welcomed the opportunity to show him the range of projects ongoing at Harvard, in both Cambridge and Longwood, that are cutting-edge, multidisciplinary and often involve collaboration with partners from other institutions, including the University of Massachusetts, and industry," Casey said.

Safer stem cells for therapy

50443248 — Thu, 25 Jun 2009 13:20:53 -0400

When stem cell researchers in Japan and the United States announced in 2007 that they had developed long-sought methods to return fully developed adult human cells to an embryonic-like state, the world of stem cell research was turned upside down.